The Bioavailability of Mycoprotein
Not Applicable
Completed
- Conditions
- Availability of Mycoprotein
- Registration Number
- NCT04233411
- Lead Sponsor
- University of Exeter
- Brief Summary
To evaluate the bioavailability of mycoprotein, compared with a reference animal based protein, in a dose-response manner.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 12
Inclusion Criteria
- Healthy and aged 18-40 y
- BMI between 18 and 30
Exclusion Criteria
- On medication
- Family history of metabolic disease
- Diagnosed with any metabolic or cardiovascular conditions
- BMI < 18 or > 30
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- CROSSOVER
- Primary Outcome Measures
Name Time Method Plasma total amino acid concentrations 4 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular pathways influence mycoprotein absorption compared to animal-based proteins in NCT04233411?
How does mycoprotein's bioavailability compare to whey or casein in dose-response trials?
Which biomarkers correlate with mycoprotein utilization in human metabolic studies?
What adverse events were observed in mycoprotein ingestion trials at the University of Exeter?
How do plant-based proteins like mycoprotein compete with soy or pea in nutritional efficacy studies?
Trial Locations
- Locations (1)
Sport & Health Sciences
🇬🇧Exeter, Devon, United Kingdom
Sport & Health Sciences🇬🇧Exeter, Devon, United Kingdom